Morgan Stanley Call 142 6MK 16.01.../ DE000ME2F030 /
26/06/2024 20:35:05 | Var.-0.01 | Denaro22:00:36 | Lettera22:00:36 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
1.28EUR | -0.78% | - Quantità in denaro: - |
- Quantità in lettera: - |
MERCK CO. D... | 142.00 - | 16/01/2026 | Call |
GlobeNewswire
23:30
Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esoph...
GlobeNewswire
23:30
Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic e...
GlobeNewswire
23:00
CenterPoint Energy, Inc. to Host Webcast of Second Quarter 2024 Earnings Conference Call
GlobeNewswire
23:00
ROHM Develops a Novel VCSELED™ Infrared Light Source that Combines Features of VCSELs and LEDs
GlobeNewswire
22:53
OV Entertainment Group Acquires Brazilian Studio Kokku Games and Argentinian Studio 3OGS
GlobeNewswire
22:41
Transforming Cancer Care: Novotech Releases Report on Radiopharmaceuticals Global Clinical Trials La...
GlobeNewswire
22:39
NeOnc Technologies Completes $18.5 Million Financing, Advances Phase II Clinical Trials for Enhanced...